Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,392,575
+$188,333 QoQ
Shares Held
5,534
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,245
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLINGENSTEIN FIELDS & CO LP holds $198,349,712 across 10 Drug Manufacturers - General names. ABBV ranks #4 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,363 | $109,583,531 | |
| 2 | JNJ |
Johnson & Johnson
|
218,394 | $55,465,523 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,496 | $28,719,236 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
5,534 | $1,392,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
8,138 | $1,028,154 | |
| 6 | BIIB |
Biogen Inc.
|
2,731 | $590,059 | |
| 7 | NVS |
Novartis AG
|
3,047 | $477,525 | |
| 8 | NVO |
Novo Nordisk A S
|
9,380 | $449,677 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,392,575 | 5,534 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,204,242 | 5,537 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,159,586 | 5,075 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,200,534 | 5,185 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $994,180 | 5,356 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,433,784 | 11,616 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,071,093 | 11,655 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,340,138 | 11,850 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,060,641 | 12,014 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,241,833 | 12,311 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,974,162 | 12,739 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,264,966 | 15,195 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,030,785 | 15,073 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,415,730 | 15,158 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,498,005 | 15,457 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,013,821 | 15,005 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,236,748 | 14,604 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,379,450 | 14,678 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,987,401 | 14,678 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,552,572 | 14,393 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,665,832 | 14,789 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,661,609 | 15,354 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,647,002 | 15,371 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,355,367 | 15,474 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,515,015 | 15,431 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,160,907 | 15,237 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||